1-16 of 16
Robert H. Getzenberg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract OT2-17-01: Randomized, multicenter, international phase 3 ARTEST study to evaluate the efficacy and safety of enobosarm versus active control for the treatment of AR+ ER+ HER2- metastatic breast cancer in patients who progressed on a nonsteroidal aromatase inhibitor, fulvestrant and CDK 4/6 inhibitor

Adam Brufsky, Hannah Linden, Hope Rugo, Charles Vogel, Joyce A O'Shaughnessy, Robert H Getzenberg, K. Gary Barnette, Domingo Rodriguez, Mitchell S Steiner, Erica Mayer
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): OT2-17-01.
https://doi.org/10.1158/1538-7445.SABCS21-OT2-17-01
Published: 15 February 2022
View article titled, Abstract OT2-17-01: Randomized, multicenter, international phase 3 ARTEST study to evaluate the efficacy and safety of enobosarm versus active control for the treatment of AR+ ER+ HER2- metastatic breast cancer in patients who progressed on a nonsteroidal aromatase inhibitor, fulvestrant and CDK 4/6 inhibitor
Journal Articles

Abstract PD8-10: Efficacy and safety of enobosarm, a selective androgen receptor modulator, to target AR in women with advanced ER+/AR+ breast cancer - final results from an international Phase 2 randomized study

Carlo Palmieri, Hannah Linden, Stephen Birrell, Elgene Lim, Lee S Schwartzberg, Hope S Rugo, Patrick Cobb, Kirti Jain, Charles Vogel, Joyce A O’Shaughnessy, Robert H Getzenberg, Mitchell S Steiner, Adam Brufsky, Beth Overmoyer
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PD8-10.
https://doi.org/10.1158/1538-7445.SABCS20-PD8-10
Published: 15 February 2021
View article titled, Abstract PD8-10: Efficacy and safety of enobosarm, a selective androgen receptor modulator, to target AR in women with advanced ER+/AR+ breast cancer - final results from an international Phase 2 randomized study
Journal Articles

Stress-Response Protein RBM3 Attenuates the Stem-like Properties of Prostate Cancer Cells by Interfering with CD44 Variant Splicing

Yu Zeng, Dana Wodzenski, Dong Gao, Takumi Shiraishi, Naoki Terada, Youqiang Li, Donald J. Vander Griend, Jun Luo, Chuize Kong, Robert H. Getzenberg, Prakash Kulkarni
Journal: Cancer Research
Cancer Res (2013) 73 (13): 4123–4133.
https://doi.org/10.1158/0008-5472.CAN-12-1343
Published: 30 June 2013
View article titled, Stress-Response Protein RBM3 Attenuates the Stem-like Properties of Prostate Cancer Cells by Interfering with CD44 Variant Splicing
Open the PDF for Stress-Response Protein RBM3 Attenuates the Stem-like Properties of Prostate Cancer Cells by Interfering with CD44 Variant Splicing in another window
Includes: Supplementary data
Journal Articles

Abstract C44: The identification and characterization of androgen-independent cells prior to hormonal manipulation in prostate cancer

Naoki Terada, Takumi Shiraishi, Yu Zeng, Koh-Meng Aw-Yong, Steven M. Mooney, Jun Luo, Prakash Kulkarni, Robert H. Getzenberg
Journal: Cancer Research
Cancer Res (2012) 72 (4_Supplement): C44.
https://doi.org/10.1158/1538-7445.PRCA2012-C44
Published: 09 May 2013
View article titled, Abstract C44: The identification and characterization of androgen-independent cells prior to hormonal manipulation in prostate cancer
Journal Articles

Abstract 1414: Lysophosphatidic acid-induced Cyr61 is associated with prostate cancer progression

Naoki Terada, Yu Zeng, Prakash Kulkarni, Robert H. Getzenberg
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 1414.
https://doi.org/10.1158/1538-7445.AM2011-1414
Published: 15 April 2011
View article titled, Abstract 1414: Lysophosphatidic acid-induced Cyr61 is associated with prostate cancer progression
Journal Articles

Eleventh Prouts Neck Meeting on Prostate Cancer: Emerging Strategies in Prostate Cancer Therapy

Evan T. Keller, David R. Rowley, Scott A. Tomlins, Charles G. Drake, Philip W. Kantoff, Kenneth J. Pienta, James E. Montie, H. Ballentine Carter, Andrew M. Hruszkewicz, Jorge Gomez, Suresh Mohla, Robert H. Getzenberg
Journal: Cancer Research
Cancer Res (2007) 67 (20): 9613–9615.
https://doi.org/10.1158/0008-5472.CAN-07-1529
Published: 17 October 2007
View article titled, Eleventh Prouts Neck Meeting on Prostate Cancer: Emerging Strategies in Prostate Cancer Therapy
Open the PDF for Eleventh Prouts Neck Meeting on Prostate Cancer: Emerging Strategies in Prostate Cancer Therapy in another window
Journal Articles

Initial Analyses of Colon Cancer–Specific Antigen (CCSA)-3 and CCSA-4 as Colorectal Cancer–Associated Serum Markers

Eddy S. Leman, Robert E. Schoen, Joel L. Weissfeld, Grant W. Cannon, Lori J. Sokoll, Daniel W. Chan, Robert H. Getzenberg
Journal: Cancer Research
Cancer Res (2007) 67 (12): 5600–5605.
https://doi.org/10.1158/0008-5472.CAN-07-0649
Published: 15 June 2007
View article titled, Initial Analyses of Colon Cancer–Specific Antigen (CCSA)-3 and CCSA-4 as Colorectal Cancer–Associated Serum Markers
Open the PDF for Initial Analyses of Colon Cancer–Specific Antigen (CCSA)-3 and CCSA-4 as Colorectal Cancer–Associated Serum Markers in another window
Includes: Supplementary data
Journal Articles

Altered Expression and Localization of Creatine Kinase B, Heterogeneous Nuclear Ribonucleoprotein F, and High Mobility Group Box 1 Protein in the Nuclear Matrix Associated with Colon Cancer

Manimalha Balasubramani, Billy W. Day, Robert E. Schoen, Robert H. Getzenberg
Journal: Cancer Research
Cancer Res (2006) 66 (2): 763–769.
https://doi.org/10.1158/0008-5472.CAN-05-3771
Published: 19 January 2006
View article titled, Altered Expression and Localization of Creatine Kinase B, Heterogeneous Nuclear Ribonucleoprotein F, and High Mobility Group Box 1 Protein in the Nuclear Matrix Associated with Colon Cancer
Open the PDF for Altered Expression and Localization of Creatine Kinase B, Heterogeneous Nuclear Ribonucleoprotein F, and High Mobility Group Box 1 Protein in the Nuclear Matrix Associated with Colon Cancer in another window
Journal Articles

Mechanistic Analysis of the Role of BLCA-4 in Bladder Cancer Pathobiology

Julie M. Myers-Irvin, Thu-Suong Van Le, Robert H. Getzenberg
Journal: Cancer Research
Cancer Res (2005) 65 (16): 7145–7150.
https://doi.org/10.1158/0008-5472.CAN-05-1142
Published: 15 August 2005
View article titled, Mechanistic Analysis of the Role of BLCA-4 in Bladder Cancer Pathobiology
Open the PDF for Mechanistic Analysis of the Role of BLCA-4 in Bladder Cancer Pathobiology in another window
Journal Articles

Detection of Prostate Cancer with a Blood-Based Assay for Early Prostate Cancer Antigen

Barbara Paul, Rajiv Dhir, Douglas Landsittel, Moira R. Hitchens, Robert H. Getzenberg
Journal: Cancer Research
Cancer Res (2005) 65 (10): 4097–4100.
https://doi.org/10.1158/0008-5472.CAN-04-4523
Published: 16 May 2005
View article titled, Detection of Prostate Cancer with a Blood-Based Assay for Early Prostate Cancer Antigen
Open the PDF for Detection of Prostate Cancer with a Blood-Based Assay for Early Prostate Cancer Antigen in another window
Journal Articles

The Group 3 LIM Domain Protein Paxillin Potentiates Androgen Receptor Transactivation in Prostate Cancer Cell Lines

Masaaki Kasai, Jennifer Guerrero-Santoro, Robert Friedman, Eddy S. Leman, Robert H. Getzenberg, Donald B. DeFranco
Journal: Cancer Research
Cancer Res (2003) 63 (16): 4927–4935.
Published: 26 August 2003
View article titled, The Group 3 LIM Domain Protein Paxillin Potentiates Androgen Receptor Transactivation in Prostate Cancer Cell Lines
Open the PDF for The Group 3 LIM Domain Protein Paxillin Potentiates Androgen Receptor Transactivation in Prostate Cancer Cell Lines in another window
Journal Articles

Identification of Nuclear Matrix Protein Alterations Associated with Human Colon Cancer

Gisela Brünagel, Barbara N. Vietmeier, Anthony J. Bauer, Robert E. Schoen, Robert H. Getzenberg
Journal: Cancer Research
Cancer Res (2002) 62 (8): 2437–2442.
Published: 01 April 2002
View article titled, Identification of Nuclear Matrix Protein Alterations Associated with Human Colon Cancer
Open the PDF for Identification of Nuclear Matrix Protein Alterations Associated with Human Colon Cancer in another window
Journal Articles

Bladder Cancer-associated Nuclear Matrix Proteins

Robert H. Getzenberg, Badrinath R. Konety, Theresa A. Oeler, Martha M. Quigley, Ardeshir Hakam, Michael J. Becich, Robert R. Bahnson
Journal: Cancer Research
Cancer Res (1996) 56 (7): 1690–1694.
Published: 01 April 1996
View article titled, Bladder Cancer-associated Nuclear Matrix Proteins
Open the PDF for Bladder Cancer-associated Nuclear Matrix Proteins in another window
Journal Articles

Expression and Alternative Splicing of the Deleted in Colorectal Cancer (DCC) Gene in Normal and Malignant Tissues

Michael A. Reale, Gang Hu, Abrahim I. Zafar, Robert H. Getzenberg, Stuart M. Levine, Eric R. Fearon
Journal: Cancer Research
Cancer Res (1994) 54 (16): 4493–4501.
Published: 01 August 1994
View article titled, Expression and Alternative Splicing of the Deleted in Colorectal Cancer (<em>DCC</em>) Gene in Normal and Malignant Tissues
Open the PDF for Expression and Alternative Splicing of the Deleted in Colorectal Cancer (<em>DCC</em>) Gene in Normal and Malignant Tissues in another window
Journal Articles

Nuclear Matrix Protein Patterns in Human Benign Prostatic Hyperplasia and Prostate Cancer

Alan W. Partin, Robert H. Getzenberg, Marne J. CarMichael, Don Vindivich, John Yoo, Jonathan I. Epstein, Donald S. Coffey
Journal: Cancer Research
Cancer Res (1993) 53 (4): 744–746.
Published: 01 February 1993
View article titled, Nuclear Matrix Protein Patterns in Human Benign Prostatic Hyperplasia and Prostate Cancer
Open the PDF for Nuclear Matrix Protein Patterns in Human Benign Prostatic Hyperplasia and Prostate Cancer in another window
Journal Articles

Identification of Nuclear Matrix Proteins in the Cancer and Normal Rat Prostate

Robert H. Getzenberg, Kenneth J. Pienta, Edwin Y. W. Huang, Donald S. Coffey
Journal: Cancer Research
Cancer Res (1991) 51 (24): 6514–6520.
Published: 01 December 1991
View article titled, Identification of Nuclear Matrix Proteins in the Cancer and Normal Rat Prostate
Open the PDF for Identification of Nuclear Matrix Proteins in the Cancer and Normal Rat Prostate in another window